Cumberland Pharmaceuticals Inc.CPIXNASDAQ
Loading
CPIX Revenue Growth (YoY Quarterly)•+31.08%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
+31.08%
+39.8pp
+35.21%
+41.1pp
-411.03%
+5779.7pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+7.05%
+0.6pp
+7.05%
+0.6pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +11.57% | +37.84% | +10.04% | -8.73% | +31.08% |
| Gross Profit Growth | +8.13% | +48.61% | +8.46% | -5.92% | +35.21% |
| EBITDA Growth | +0.00% | +0.00% | +52.05% | -6190.71% | -411.03% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | -1.36% | +5.99% | +5.97% | +6.41% | +7.05% |
| Weighted Average Shares Diluted Growth | -1.36% | +8.24% | +5.97% | +6.41% | +7.05% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +83.12% | +0.00% | +0.00% | -60.64% | -99.84% |
| Free Cash Flow Growth | +96.96% | +0.00% | +0.00% | -68.35% | -99.84% |
| Receivables Growth | +19.91% | -1.50% | -11.21% | -7.78% | +44.81% |
| Inventory Growth | -13.22% | -5.28% | -25.09% | -34.92% | +55.64% |
| Asset Growth | -7.57% | -14.20% | -13.52% | -14.14% | +1.64% |
| Book Value per Share Growth | -21.73% | -1.64% | +0.25% | -0.94% | +1.70% |
| Debt Growth | +11.63% | -51.77% | -52.06% | -52.34% | -50.51% |
| R&D Expense Growth | +2.21% | +11.81% | +38.63% | -4.04% | +19.88% |
| SG&A Expenses Growth | -7.92% | +2.64% | +1.33% | -0.95% | +35.72% |
1 / 4